Health

Himachal Pradesh Initiates Recall Of 47 Medicine Batches Following Quality Test Failures

Himachal Pradesh has instructed pharmaceutical companies to immediately recall 47 batches of medicines after they did not meet quality standards, officials confirmed on December 20, 2025.

Authorities have sent formal notices directing manufacturers to remove the affected stock from the market without delay.

“Out of 200 medicine samples tested nationwide, 47 were manufactured in the State. These include medications for fever, heart attacks, and diabetes. The failed samples originated from various districts: 28 from Solan, 18 from Sirmaur, and one from Una. Notices have been issued to the respective companies,” officials said on Saturday.

The affected medicines include Paracetamol for fever, Clopidogrel and Aspirin for heart conditions, Metformin for diabetes, Ramipril for heart ailments, Sodium Valproate for epilepsy, and Mebeverine Hydrochloride for muscle spasms, among others that failed to meet safety standards.

“Explanations have been sought, and actions will be taken against the companies in accordance with regulations,” State Drug Controller Manish Kapoor informed media personnel in Solan.

Testing and Regulatory Oversight

In November 2025, the Central Drugs Standard Control Organisation (CDSCO) collected 65 samples, while the Himachal Pradesh State Drug Controller tested 135. Out of these, 47 were confirmed substandard, prompting immediate recall and further scrutiny.

Himachal Pradesh has faced repeated issues with medicines produced locally failing quality tests. Earlier this year, Health Minister Dhani Ram Shandil warned that companies with recurrent violations could be blacklisted.

Moreover, a central regulator alert in March 2025 had highlighted 38 drug samples from the state that failed to meet standards.

Officials emphasise that public safety remains the top priority, and strict measures will continue against non-compliant pharmaceutical companies. The current recall aims to prevent unsafe medicines from reaching patients while reinforcing adherence to national drug quality regulations.

The state government has urged manufacturers to implement corrective measures immediately and to comply fully with recall instructions.

Regular testing and monitoring will continue to ensure that medicines produced in Himachal Pradesh adhere to the highest quality standards. This measure will help protect public health.

Also Read: Govt To Introduce Bill Against Fake Fertilisers, Pesticides In Next Parliament Session: Shivraj Singh Chouhan

Bishal Singh

Recent Posts

Voyager 1 Travels 25.9 Billion Kilometres, Continues Sending Data From Interstellar Space

NASA’s Voyager 1 spacecraft, launched in 1977 for a mission lasting just four to five…

3 hours ago

Muslims Projected To Surpass Christians As World’s Largest Religious Group By 2035

Muslims are projected to become the world’s largest religious group by 2035, with population growth…

3 hours ago

PM Modi Meets Prince William And Kate, Reaffirms India-UK Strategic Partnership

Prime Minister Narendra Modi met Prince William and Princess Kate in New Delhi, discussed strengthening…

3 hours ago

PM Modi’s Manila Gurdwara Engagement Highlighted India’s Outreach To Sikh Community

Prime Minister Narendra Modi attended the redevelopment launch of Gurdwara Khalsa Diwan in Manila during…

4 hours ago

‘Jai Chhathi Maiya’ Echoed In London As Anil Agarwal Celebrated Chhath With Indian Diaspora

Vedanta Chairman Anil Agarwal joined Chhath Puja celebrations in London, where hundreds of devotees observed…

4 hours ago

Keralam Chief Minister VD Satheesan Meets Prime Minister Narendra Modi

Keralam Chief Minister VD Satheesan met Prime Minister Modi in New Delhi, marking a meeting…

5 hours ago